These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30588883)

  • 1. Design of Experiments (DoE) Approach to Optimize the Sustained Release Microparticles of Gefitinib.
    Soni G; Yadav KS; Gupta MK
    Curr Drug Deliv; 2019; 16(4):364-374. PubMed ID: 30588883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells.
    Shen Y; TanTai J
    Drug Des Devel Ther; 2020; 14():4503-4510. PubMed ID: 33122893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.
    Chen W; Palazzo A; Hennink WE; Kok RJ
    Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W
    Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication and characterization of gefitinib-releasing polyurethane foam as a coating for drug-eluting stent in the treatment of bronchotracheal cancer.
    Chen W; di Carlo C; Devery D; McGrath DJ; McHugh PE; Kleinsteinberg K; Jockenhoevel S; Hennink WE; Kok RJ
    Int J Pharm; 2018 Sep; 548(2):803-811. PubMed ID: 29031981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System.
    Zhu C; Peng T; Huang D; Feng D; Wang X; Pan X; Tan W; Wu C
    AAPS PharmSciTech; 2019 Jan; 20(2):64. PubMed ID: 30627822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
    Wu C; Luo X; Baldursdottir SG; Yang M; Sun X; Mu H
    Eur J Pharm Biopharm; 2019 Sep; 142():315-321. PubMed ID: 31299277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a zero-order sustained release PLGA microspheres for palonosetron hydrochloride with high encapsulation efficiency.
    Yang Z; Liu L; Su L; Wu X; Wang Y; Liu L; Lin X
    Int J Pharm; 2020 Feb; 575():119006. PubMed ID: 31899319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy.
    Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN
    Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Release of Risedronate from PLGA Microparticles Embedded in Alginate Hydrogel for Treatment of Bony Lesions.
    Azari G; Aghayan S; Seyedjafari E
    Iran Biomed J; 2022 Mar; 26(2):124-31. PubMed ID: 35090303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Characterization of Olanzapine Loaded Poly(lactide-coglycolide) Microspheres for Depot Injection: In vitro and In vivo Release Profiles.
    Pervaiz F; Ahmad M; Li L; Murtaza G
    Curr Drug Deliv; 2019; 16(4):375-383. PubMed ID: 30588882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
    Sweet JL; Pillay V; Choonara YE
    Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
    Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
    J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
    Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
    Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of poly(lactide-co-glycolide) microparticles for sustained delivery of meloxicam.
    Pei Y; Wang J; Khaliq NU; Meng F; Oucherif KA; Xue J; Horava SD; Cox AL; Richard CA; Swinney MR; Park K; Yeo Y
    J Control Release; 2023 Jan; 353():823-831. PubMed ID: 36521690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.